Banque Transatlantique Sa Vertex Pharmaceuticals Inc Transaction History
Banque Transatlantique Sa
- $3.94 Billion
- Q3 2025
A detailed history of Banque Transatlantique Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Banque Transatlantique Sa holds 614 shares of VRTX stock, worth $266,488. This represents 0.01% of its overall portfolio holdings.
Number of Shares
614
Previous 776
20.88%
Holding current value
$266,488
Previous $345,000
30.43%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...